文献速递其他结缔组织病

51例原发性干燥综合征患者SARS-CoV-2感染特征与结局

SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究基于国际多中心Big Data Sjögren登记库,分析了51例原发性干燥综合征(pSS)合并SARS-CoV-2感染患者的预后与结局。估计感染频率为0.62%(95%CI 0.44,0.80),49%需住院、4例死亡;基线合并症与住院风险升高相关(校正OR 6.01,95%CI 1.72,23.51)。

要点

  • pSS患者SARS-CoV-2感染估计频率0.62%(95%CI 0.44,0.80),49%需住院、4例死亡。
  • 合并症患者住院风险为无合并症者的6倍(校正OR 6.01,95%CI 1.72,23.51)。

核心结论

  • 基线合并症是pSS患者COVID-19更复杂的关键危险因素,与无合并症者相比住院率更高、结局更差。

研究设计与样本

  • 国际多中心Big Data Sjögren登记库中按2002/2016分类标准诊断的pSS患者,SARS-CoV-2感染定义依据欧洲疾病预防控制中心指南,共纳入51例(46例女性,感染诊断时平均年龄60岁)。

主要发现

  • 除2例外均有COVID-19提示症状:发热82%、咳嗽57%、呼吸困难39%、乏力/肌痛27%、腹泻24%。
  • 最常见实验室异常为LDH升高88%、CRP升高81%、D-二聚体升高82%、淋巴细胞减少70%。
  • 26例(51%)居家管理,25例(49%)需住院,其中5例入住ICU、4例死亡。
  • 合并症患者年龄更大(校正OR 1.05,95%CI 1.00,1.11),住院风险为无合并症者的6倍(校正OR 6.01,95%CI 1.72,23.51)。

关键数值与推荐

  • 以登记库中pSS评估患者数(n=8211)为分母,SARS-CoV-2感染估计频率为0.62%(95%CI 0.44,0.80)。

临床怎么用

  • 对合并基础疾病的pSS患者应警惕COVID-19住院与不良结局风险,关注淋巴细胞减少等实验室异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyse the prognosis and outcomes of SARS-CoV-2 infection in patients with primary SS. METHODS: We searched for patients with primary SS presenting with SARS-CoV-2 infection (defined following and according to the European Centre for Disease Prevention and Control guidelines) among those included in the Big Data Sjögren Registry, an international, multicentre registry of patients diagnosed according to the 2002/2016 classification criteria. RESULTS: A total of 51 patients were included in the study (46 women, mean age at diagnosis of infection of 60 years). According to the number of patients with primary SS evaluated in the Registry (n = 8211), the estimated frequency of SARS-CoV-2 infection was 0.62% (95% CI 0.44, 0.80). All but two presented with symptoms suggestive of COVID-19, including fever (82%), cough (57%), dyspnoea (39%), fatigue/myalgias (27%) and diarrhoea (24%), and the most frequent abnormalities included raised lactate dehydrogenase (LDH) (88%), CRP (81%) and D-dimer (82%) values, and lymphopenia (70%). Infection was managed at home in 26 (51%) cases and 25 (49%) required hospitalization (five required admission to ICU, four died). Compared with patients managed at home, those requiring hospitalization had higher odds of having lymphopenia as laboratory abnormality (adjusted OR 21.22, 95% CI 2.39, 524.09). Patients with comorbidities had an older age (adjusted OR 1.05, 95% CI 1.00, 1.11) and showed a risk for hospital admission six times higher than those without (adjusted OR 6.01, 95% CI 1.72, 23.51) in the multivariate analysis. CONCLUSION: Baseline comorbidities were a key risk factor for a more complicated COVID-19 in patients with primary SS, with higher rates of hospitalization and poor outcomes in comparison with patients without comorbidities.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Brito-Zerón P, Melchor S, Seror R, et al. SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients. Rheumatology (Oxford). 2021. PMID: 33316070. doi:10.1093/rheumatology/keaa748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。